Matches in Nanopublications for { ?s ?p "[Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP751436.RABdf-hqWsvfZQq0Mn14flP8JGpagyo5J9YObMDjK4WeY130_assertion description "[Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP751436.RABdf-hqWsvfZQq0Mn14flP8JGpagyo5J9YObMDjK4WeY130_provenance.
- assertion description "[Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP550718.RATGe3hEoUXc0ityhxSH8nc09qx0Qa-OuUlmAWtdWLxAo130_assertion description "[Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP550718.RATGe3hEoUXc0ityhxSH8nc09qx0Qa-OuUlmAWtdWLxAo130_provenance.
- NP878752.RA-1B_eJh_rdHui8OFaOvsoqZMH-uUhGw-GH_Muo7yJjQ130_assertion description "[Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878752.RA-1B_eJh_rdHui8OFaOvsoqZMH-uUhGw-GH_Muo7yJjQ130_provenance.
- NP878753.RAyBc6GKiRKNE_RCx8fBPSLh3F5ZCPcbLsrrLoorIy0gA130_assertion description "[Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878753.RAyBc6GKiRKNE_RCx8fBPSLh3F5ZCPcbLsrrLoorIy0gA130_provenance.
- assertion description "[Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP878751.RAvtYox7utPLtgC54r_sUE4k4z5VzHGKGRvS05ZT-UVPo130_assertion description "[Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878751.RAvtYox7utPLtgC54r_sUE4k4z5VzHGKGRvS05ZT-UVPo130_provenance.